Edwards Lifesciences Corporation v. Abbott Cardiovascular Systems, Inc.
Edwards Lifesciences Corporation v. Abbott Cardiovascular Systems, Inc.
Trial Court Opinion
1
2
3
4
5
6
7
8 UNITED STATES DISTRICT COURT 9 CENTRAL DISTRICT OF CALIFORNIA 10 SOUTHERN DIVISION 11 EDWARDS LIFESCIENCES Case No. 8:19-cv-00345-JLS-JDE
CORPORATION, a Delaware corporation, 12 and EDWARDS LIFESCIENCES LLC, a PROTECTIVE ORDER 13 Delaware corporation
14 Plaintiffs, [Discovery Document: Referred to 15 v. Magistrate Judge John D. Early]
16 ABBOTT CARDIOVASCULAR SYSTEMS, INC., a California corporation, 17 Defendant. 18
19 Based upon the Stipulation (Dkt. 53-1) of the parties in the above-captioned
20 action (the “Action”), pursuant to Rule 26(c) of the Federal Rules of Civil Procedure,
21 the Court hereby orders the parties to abide by, this Protective Order on
22 Confidentiality (the “Protective Order”). The Court alters the proposed protective
23 order otherwise stipulated to by the parties to: (a) reflect that the Protective Order
24 does not govern the use or introduction of evidence at trial, which will be determined
25 exclusively by the trial judge; (b) clarify that nothing in the Protective Order
26 authorizes a person or party to disobey a lawful order or process issued by another
27 court (see ¶ 23); and (c) delete a requirement that the parties contact a “Judicial
Administrator” to schedule a hearing (see ¶ 12). 1 This Protective Order shall govern disclosures, production and handling of
2 documents, answers to interrogatories, responses to requests for admissions,
3 depositions, testimony at pretrial hearings, pleadings, exhibits, and other
4 information or tangible things that qualify for protection under Federal Rule of Civil
5 Procedure 26(c), exchanged by the parties, produced by third parties, or filed with the
6 Court in this Action (collectively, “Exchanged Information”). In support of this
7 Order, the Court finds that:
8 GOOD CAUSE STATEMENT
9 This Action is likely to involve trade secrets, customer and pricing lists and
10 other valuable research, development, commercial, financial, technical and/or
11 proprietary information for which special protection from public disclosure and from
12 use for any purpose other than prosecution of the litigations between the parties
13 is warranted. Such confidential and proprietary materials and information consist of,
14 among other things, confidential business or financial information, information
15 regarding confidential business practices, or other confidential research,
16 development, or commercial information (including information implicating
17 privacy rights of third parties), information otherwise generally unavailable to the
18 public, or which may be privileged or otherwise protected from disclosure under state
19 or federal statutes, court rules, case decisions, or common law. The parties
20 acknowledge that disclosure of this information would cause competitive harm to
21 the parties. For example, the parties believe that competitors will gain an unfair
22 advantage if they learn the parties’ Confidential Information, such as financial
23 information, accounting information, customer lists, vendor lists, costs or profits
24 structure, sales information, proprietary product designs, product lines, business
25 and marketing strategy or information about operations. Accordingly, to expedite
26 the flow of information, to facilitate the prompt resolution of disputes over
27 confidentiality of discovery materials, to adequately protect information the parties
are entitled to keep confidential, to ensure that the parties are permitted reasonable 1 necessary uses of such material in preparation for trial, to address their handling at
2 the end of the litigation, and serve the ends of justice, a protective order for such
3 information is justified in this matter. It is the intent of the parties that information
4 will not be designated as confidential for tactical reasons and that nothing be so
5 designated without a good faith belief that it has been maintained in a confidential,
6 non-public manner, and there is good cause why it should not be part of the public
7 record of this case.
8 ACKNOWLEDGMENT OF PROCEDURE FOR
9 FILING UNDER SEAL
10 As set forth in Section 23, below, this Protective Order does not entitle the
11 parties to file confidential information under seal; Local Civil Rule 79-5 sets forth the
12 procedures that must be followed and the standards that will be applied when a party
13 seeks permission from the court to file material under seal.
14 There is a strong presumption that the public has a right of access to judicial
15 proceedings and records in civil cases. In connection with non-dispositive motions,
16 good cause must be shown to support a filing under seal. See Kamakana v. City &
17 County of Honolulu,
447 F.3d 1172, 1176 (9th Cir. 2006), Phillips v. Gen. Motors
18 Corp.,
307 F.3d 1206, 1210-11 (9th Cir. 2002), Makar-Welbon v. Sony Electrics,
19 Inc.,
187 F.R.D. 576, 577(E.D. Wis. 1999) (even stipulated protective orders
20 require good cause showing), and a specific showing of good cause or compelling
21 reasons with proper evidentiary support and legal justification, must be made with
22 respect to Confidential Information that a party seeks to file under seal. The parties’
23 mere designation of Exchanged Information as Confidential Information does not—
24 without the submission of competent evidence by declaration, establishing that the
25 material sought to be filed under seal qualifies as confidential, privileged, or
26 otherwise protectable—constitute good cause.
27 Further, if a party requests sealing related to a dispositive motion or trial, then
compelling reasons, not only good cause, for the sealing must be shown, and the relief 1 sought shall be narrowly tailored to serve the specific interest to be protected. See
2 Pintos v. Pacific Creditors Ass’n,
605 F.3d 665, 677-79(9th Cir. 2010). For each
3 item or type of information, document, or thing sought to be filed or introduced under
4 seal in connection with a dispositive motion or trial, the party seeking protection must
5 articulate compelling reasons, supported by specific facts and legal justification, for
6 the requested sealing order. Again, competent evidence supporting the application
7 to file documents under seal must be provided by declaration.
8 Any document that is not confidential, privileged, or otherwise protectable in
9 its entirety will not be filed under seal if the confidential portions can be
10 redacted. If documents can be redacted, then a redacted version for public viewing,
11 omitting only the confidential, privileged, or otherwise protectable portions of the
12 document, shall be filed. Any application that seeks to file documents under seal in
13 their entirety should include an explanation of why redaction is not feasible.
14 The parties shall serve redacted versions of any documents filed under seal
15 within 48 hours of the filing and shall take reasonable measures to minimize
16 redactions to documents filed under seal.
17 SCOPE
18 1. The protections conferred by this Order cover not only Exchanged
19 Information, but also (1) any information copied or extracted from Exchanged
20 Information; (2) all copies, excerpts, summaries, or compilations of Exchanged
21 Information; and (3) any testimony, conversations, or presentations by parties or
22 their counsel that might reveal Exchanged Information. However, the protections
23 conferred by this Order do not cover the following information: (a) any information
24 that is in the public domain at the time of disclosure to a receiving party or becomes
25 part of the public domain after its disclosure to a receiving party as a result of
26 publication not involving a violation of this Order, including information that
27 has become part of the public record through trial or otherwise; and (b) any
information known to the receiving party prior to the disclosure or obtained by the 1 receiving party after the disclosure from a source who obtained the information
2 lawfully and under no obligation of confidentiality to the designating party.
3 DISCLOSURE AND USE OF CONFIDENTIAL INFORMATION
4 2. Any party or non-party may designate as “CONFIDENTIAL,”
5 “HIGHLY CONFIDENTIAL ATTORNEYS’ EYES ONLY,” or “PROSECUTION
6 BAR INFORMATION” any Exchanged Information that contains non-public,
7 sensitive trade secret, marketing, customer, financial, research, product-
8 development, regulatory, manufacturing/distribution or other information
9 protectable under Federal Rule of Civil Procedure 26(c)(1)(G) (collectively
10 “Confidential Information”).
11 3. The parties are currently litigating in a second action in the District of
12 Delaware: Abbott Cardiovascular Systems, Inc. et al v. Edwards Lifesciences Corp.
13 et al, No. 19-149-MN (D. Del.) (“the Delaware Action”). Subject to the provisions
14 of this Protective Order, and any protective order entered in the Delaware Action,
15 documents and things produced in this Action by a party or non-party under this
16 Protective Order may also be used and disclosed by the parties in the Delaware
17 Action as if they had been produced in that Action.
18 The production of any documents under this paragraph is not an admission of
19 relevance or admissibility for any given action.
20 4. Confidential Information of the disclosing party shall be used by
21 receiving parties solely for purposes of this Action, or as set forth in paragraph 3
22 above, or absent a court order, except that the parties are permitted to disclose
23 Confidential Information to no more than a total of two foreign attorneys (or, in the
24 UK, where both barristers and solicitors are engaged as counsel of record no more
25 than three foreign attorneys) representing the Party and/or its related entities in each
26 of the “Related Foreign Actions” listed below (“Designated Foreign Counsel”)1, and
27 1 If an attorney who is counsel of record in any of the Related Foreign Actions is also counsel of record in another Related Foreign Action, then that 1 their clerical employees and assistants, for purposes of providing advice and
2 counseling with respect to coordination only and not for use in the Related Foreign
3 Actions. Such Confidential Information may not be disclosed to the court or
4 decision-making body or otherwise relied upon as evidence in any of the Related
5 Foreign Actions absent a court order. For the avoidance of doubt, this provision does
6 not restrict the use of Confidential Information for any purpose if that Confidential
7 Information was rightfully obtained by means other than through discovery in this
8 Action. Prior to disclosure of Confidential Information to Designated Foreign
9 Counsel, the party seeking disclosure shall provide written notice to the producing
10 party identifying the names of the Designated Foreign Counsel. If the producing
11 party objects to the disclosure of Confidential Information to the Designated Foreign
12 Counsel, the producing party shall object in writing, within five (5) business days
13 of receipt of the written notice and state the basis for its objection. Within five (5)
14 business days of the written objection, the parties shall meet and confer. If the parties
15 do not reach resolution, the party seeking disclosure shall follow the procedures set
16 forth by the Court for raising discovery disputes with the Court. The Related Foreign
17 Actions are:
18 a. Abbott Medical GmbH v. Edwards Lifesciences Corp. and
19 Edwards Lifesciences Services GmbH, Ref. No. 4b O 8/19 (Germany);
20 b. Abbott Cardiovascular Systems Inc., Evalve Inc., and Abbott
21 Medical Italia SpA v. Edwards Lifesciences LLC and Edwards Lifesciences
22 Italia SpA, Docket No. 4251/2019/CC (Italy);
23 c. Evalve, Inc., Abbott Cardiovascular Systems, Inc., and Abbott
24 Medical (Schweiz) AG v. Edwards Lifesciences SA, Edwards Lifesciences
25 Technology sàrl, Edwards Lifesciences IPRM SA, and Mitral Valve
26 Technologies sàrl, Docket No. S2019_002 (Switzerland);
27 d. Evalve Inc., Abbott Cardiovascular Systems., Inc., and Abbott
Medical U.K. Ltd. v. Edwards Lifesciences Ltd., Claim No. HP-2019- 000003 1 (United Kingdom);
2 e. Opposition by Edwards Lifesciences Corporation to EP 1 626
3 810 (Application No. EP04752603.3); and
4 f. such other foreign actions as may be agreed by the parties such
5 agreement not to be withheld without reasonable basis.
6 5. Confidential Information shall be initially produced only to outside
7 counsel of record representing the parties in this Action.
8 6. Outside counsel of record may disclose the respective categories of
9 Confidential Information to the following persons for use in connection with this
10 Action under the conditions set forth in this Protective Order, or in connection with
11 a Related Foreign Action solely as provided for by Paragraph 4 above:
12 a. Information designated as PROSECUTION BAR
13 INFORMATION (including, pursuant to Paragraph 10(d), information
14 designated as HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES ONLY
15 before the date of this Protective Order):
16 1. (a) other outside counsel who have been retained by the
17 parties with respect to this Action, including all attorneys,
18 paralegals, law students, stenographic and clerical employees
19 working under the supervision of such counsel, as
20 well as court reporters, interpreters, translators,
21 copy services, litigation support (including
22 document imaging), and database/coding services retained by
23 counsel or (b) Designated Foreign Counsel in a Related
24 Foreign Action;
25 2. any expert or consultant, not an employee of a party, who is
26 retained to assist in preparation of this Action for trial, and
27 clerical employees, assistants, researchers and technicians of,
or under the supervision of, such experts, with disclosure only 1 to the extent necessary to perform such work;
2 3. the Court, under seal as provided in this Protective Order;
3 4. in-house attorneys who are (a) providing instruction and/or
4 assistance to outside counsel with respect to this Action and
5 who are qualified to access PROSECUTION BAR
6 INFORMATION, pursuant to paragraph 7 below, and (b)
7 subject to a Prosecution Bar as defined below;
8 5. court reporters present in their official capacity at a hearing,
9 deposition, or other proceeding in this Action;
10 6. professional jury or trial consultants and mock jurors who
11 have signed the Declaration (Exhibit A), which does not need
12 to be disclosed to the designating party unless the Court for
13 good cause orders otherwise; and
14 7. graphics or design consultants retained to prepare
15 demonstratives or other exhibits for use in this Action.
16 b. Information designated as HIGHLY CONFIDENTIAL –
17 ATTORNEYS’ EYES ONLY after the date of this Protective Order:
18 1. those persons described in Paragraph 6(a); and
19 2. in-house attorneys who are (a) providing instruction and/or
20 assistance to outside counsel with respect to this Action and
21 who are qualified to access HIGHLY CONFIDENTIAL –
22 ATTORNEYS’ EYES ONLY information, pursuant to
23 Paragraph 7 below, and (b) not subject to a Prosecution Bar as
24 defined below.
25 c. Information designated as CONFIDENTIAL:
26 1. those persons described in Paragraphs 6(a) and 6(b); and
27 2. in-house attorneys who are (a) providing instruction and/or
assistance to outside counsel with respect to this Action and 1 who are qualified to access CONFIDENTIAL information,
2 pursuant to Paragraph 7 below, and (b) not subject to a
3 Prosecution Bar as defined below.
4 7. The parties have agreed that the following in-house attorneys and
5 attorney consultant have met the requirements of paragraph 6(a), 6(b), or 6(c) and
6 may have access to PROSECUTION BAR INFORMATION, HIGHLY
7 CONFIDENTIAL-ATTORNEYS’ EYES ONLY Information or CONFIDENTIAL
8 Information, as specifically noted below, in accordance with the provisions of this
9 Protective Order:
10 a. For Plaintiffs:
11 1. PROSECUTION BAR INFORMATION, HIGHLY
12 CONFIDENTIAL – ATTORNEYS’ EYES ONLY Information, and
13 CONFIDENTIAL Information:
14 A. Arnold Pinkston, General Counsel, Edwards Lifesciences;
15 B. Aimee Weisner, Consultant, Edwards Lifesciences;
16 C. Ryan Lindsey, Senior IP Counsel, IP & Litigation,
17 Edwards Lifesciences; and
18 C. Avi Schwartz, IP Counsel, Edwards Lifesciences.
19 2. CONFIDENTIAL Information:
20 A. Keith Newburry, VP, Chief Intellectual Property Counsel,
21 Edwards Lifesciences
22 b. For Defendant
23 1. PROSECUTION BAR INFORMATION, HIGHLY
24 CONFIDENTIAL – ATTORNEYS’ EYES ONLY Information, and
25 CONFIDENTIAL Information:
26 A. Hubert Allen, Executive Vice President, General Counsel
27 and Secretary, Abbott Laboratories;
B. Jennifer Embry, Senior Counsel, Intellectual Property 1 Litigation, Abbott Laboratories;
2 C. David Mendelson, Divisional Vice President and
3 Associate General Counsel, Litigation, Abbott Laboratories;
4 D. Gary Schneiderman, fmr. Division Counsel, Patent
5 Litigation, Abbott Laboratories; and
6 E. Ronald Devore, Division Counsel, Patents, Abbott
7 Laboratories.
8 2. HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES ONLY
9 Information and CONFIDENTIAL Information:
10 A. Paul Yasger, Divisional Vice President, Associate General
11 Counsel, and Chief Patent Counsel, Abbott Laboratories.
12 c. The parties may seek to designate substitute in-house attorneys
13 according to the provisions of this Protective Order. Prior to disclosure of
14 Confidential Information to such persons, the party seeking disclosure shall
15 provide written notice to the producing party identifying the names of
16 additional designees. If the producing party objects to the disclosure of
17 Confidential Information to such additional designees, the producing party
18 shall object in writing, within five (5) business days of receipt of the written
19 notice and state the basis for its objection. Within five (5) business days of the
20 written objection, the parties shall meet and confer. If the parties do not reach
21 resolution, the party seeking disclosure shall follow the procedures set forth
22 by the Court for raising discovery disputes with the Court.
23 8. Prior to the disclosure of any Confidential Information to those
24 persons described in Paragraphs 6(a)(4), 6(b)(2), and 6(c)(2) or to any outside counsel
25 not of record in this Action, each of those persons must read this Protective Order
26 and sign the Declaration (Attachment A hereto). A copy of such signed Declaration
27 must be retained by outside counsel of record for the party disclosing the
Confidential Information under the terms of this Protective Order until the 1 termination of this Action (including any appeals).
2 9. Persons receiving Confidential Information are prohibited from
3 disclosing it, or any information derived therefrom, to any person except in
4 conformance with this Protective Order.
5 DEFINITION OF CONFIDENTIAL INFORMATION
6 10. Criteria for Classification:
7 a. A party or non-party may designate Confidential Information as
8 CONFIDENTIAL if the producing party or non-party reasonably believes that
9 the information contains or discloses trade secrets or other non-public
10 technical, personal, or commercial information, or contains or discloses
11 information protected by a right to privacy under federal or state law or any
12 other applicable privilege or right related to confidentiality or privacy;
13 b. A party or non-party may designate Confidential Information as
14 HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES ONLY if the
15 producing party or non-party reasonably believes that such information (i)
16 satisfies the criteria for designation as CONFIDENTIAL, under Paragraph
17 10(a) above, (ii) is extremely sensitive Confidential Information, the
18 disclosure of which to another party or non-party would create a substantial
19 risk of serious harm that could not be avoided by less restrictive means, and
20 (iii) discloses information relating to: a party or non-party's manufacturing,
21 processing, and/or developing of any products or product-candidates
22 (including, but not limited to, sensitive research materials, development
23 materials and strategic plans), scientific research, customers, or pricing and
24 sales information. Subject to the foregoing, such HIGHLY CONFIDENTIAL
25 ATTORNEYS’ EYES ONLY information may include without limitation:
26 trade secrets; technical information; technical practices, methods, or other
27 know-how; pending but unpublished patent applications; Board materials;
pricing data; financial data; sales information; customer-confidential 1 information; agreements or relationships with third parties; market projections
2 or forecasts; strategic business plans, selling or marketing strategies; new
3 product development; testing; manufacturing costs; or information regarding
4 employees.
5 c. A party or non-party may designate Confidential Information as
6 PROSECUTION BAR INFORMATION if, the producing party or non-party
7 reasonably believes that such information (i) satisfies the criteria for
8 designation as HIGHLY CONFIDENTIAL - ATTORNEYS’ EYES ONLY,
9 under Paragraph 10(b) above, and (ii) raises genuine and reasonable concerns
10 that it could be improperly used in the prosecution of a patent application by
11 the receiving party.
12 d. Notwithstanding the foregoing, any document or other
13 information designated as HIGHLY CONFIDENTIAL - ATTORNEYS’
14 EYES ONLY before the entry of this Protective Order (including at least
15 ABT0000001-1193540 and EDW-ABT00000001 - 00734304) shall be
16 treated as if it were designated as PROSECUTION BAR INFORMATION.
17 EXPERTS
18 11. For any expert proposed to be designated pursuant to Paragraph
19 6(a)(2) the party seeking to disclose Confidential Information to the expert first must
20 provide to all attorneys of record for the other parties a written notice that: (1)
21 attaches the expert’s signed Declaration (Attachment A hereto), (2) sets forth the full
22 name of the proposed recipient and the city and state of his or her primary residence;
23 (3) attaches a copy of the proposed recipient's current resume; (4) identifies the
24 proposed recipient’s current employer(s); (5) identifies (to the extent permitted
25 without violating any third-party confidentiality obligation) each person or entity
26 from whom the proposed recipient has received compensation or funding for work in
27 his or her areas of expertise or to whom the proposed recipient has provided
professional services, including in connection with litigation, at any time during the 1 preceding five years; and (6) identifies (by name and number of the case, filing date,
2 and location of court, if known) any litigation in connection with which the expert
3 has offered expert testimony, including through a declaration, report, or testimony
4 at a deposition or at trial during the preceding four years.2
5 12. Unless counsel for the party that produced the Confidential Information
6 notifies the proposing attorney in writing of an objection to the proposed
7 designee within five (5) business days of receipt of notification, such designee shall
8 be deemed qualified to receive Confidential Information. In the event of an
9 objection, the parties shall first informally try to resolve the objection in good faith
10 within three (3) business days. If the objection cannot be resolved, the parties may
11 request appropriate relief from the Court through the Court’s procedures for
12 resolving disputes regarding discovery matters or other expedited procedure. The
13 parties specifically reserve the right to object to the disclosure of Confidential
14 Information to a proposed expert should the proposed expert be employed by the
15 objecting party’s competitor. The burden of proving that the designated person
16 should not be designated is on the objecting party.
17 DESIGNATION OF CONFIDENTIAL INFORMATION
18 13. Each party or non-party that designates information or items for
19 protection under this Order must take care to limit any such designation to specific
20 material that qualifies under the appropriate standards. To the extent it is practical to
21 do so, the designating party must designate for protection only those parts of
22 material, documents, items, or oral or written communications that qualify - so that
23 other portions of the material, documents, items, or communications for which
24 protection is not warranted are not swept unjustifiably within the ambit of this Order.
25 2 If the proposed expert believes any of this information specified in Paragraph 11 (5) or 26 (6) is subject to a confidentiality obligation to a third party, then the proposed expert should provide whatever information the proposed expert believes can be disclosed without violating 27 any confidentiality agreements. The party seeking to disclose to the proposed expert should notify the other party that information has been withheld and describe the nature of the withheld 1 Notwithstanding the foregoing, to the extent that only a portion of a court filing or
2 expert report qualifies as PROSECUTION BAR INFORMATION, the parties agree
3 to provide the other side with a copy that identifies the portion of the filing or expert
4 report that contains PROSECUTION BAR INFORMATION on the following
5 schedule: (a) for court filings (except exhibits), by 6 pm PT on the next business day
6 after the court filing is filed; (b) for exhibits to court filings, within seven (7) calendar
7 days after the court filing is filed; and (c) for expert reports, within three (3) calendar
8 days after the expert report is served; for production documents, the producing party
9 may designate the entire document as PROSECUTION BAR INFORMATION. For
10 documents other than court filings and expert reports, if a receiving party requests
11 that the producing party identify the particular portions that contain
12 PROSECUTION BAR INFORMATION, HIGHLY CONFIDENTIAL-
13 ATTORNEYS’ EYES ONLY INFORMATION, or CONFIDENTIAL
14 INFORMATION, the producing party shall do so, but such requests will count
15 toward the numerical limits in Paragraph 16 below.
16 14. Parties shall designate Confidential Information as follows:
17 a. In the case of information in documentary form (e.g., paper or
18 electronic documents, but excluding transcripts of depositions or other pretrial
19 or trial proceedings), designation shall be made by placing prior to production
20 the following legends on each page of such document (or each page that
21 contains Confidential Information if that can be practically determined);
22 CONFIDENTIAL or HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES
23 ONLY or PROSECUTION BAR INFORMATION. For pleadings and
24 discovery responses, such marking need only appear on the first page of
25 the document. Any Confidential Information not reduced to documentary or
26 physical form or which cannot be conveniently labeled shall be so designated
27 by a party by serving a written notification on the receiving party within a
reasonable amount of time after disclosure. 1 b. To the extent that a party initially produces documents for
2 inspection (i.e., prior to making copies), no marking need be made by the
3 producing party in advance of the inspection. For purposes of the inspection,
4 all documents shall be treated as containing HIGHLY CONFIDENTIAL -
5 ATTORNEYS’ EYES ONLY Information. After the receiving party selects
6 specified documents for copying, the producing party shall appropriately
7 mark the copies of the selected documents by placing prior to production the
8 following legends on each page of such document that contains Confidential
9 Information; CONFIDENTIAL or HIGHLY CONFIDENTIAL –
10 ATTORNEYS’ EYES ONLY or PROSECUTION BAR INFORMATION.
11 c. In the case of transcripts of depositions or other pretrial
12 proceedings, designation of the portion of the original and all copies of any
13 transcript (including exhibits) which contains Confidential Information shall
14 be made by a statement to such effect on the record in the course of the
15 proceeding or upon review of such transcript by counsel for the party whose
16 Confidential Information is discussed in the transcript. Such designation
17 shall be provided to opposing counsel within five (5) business days after
18 counsel's receipt of the final transcript of the proceeding. Unless otherwise
19 agreed by the parties in writing or on the record at the proceeding, all
20 transcripts shall be treated as PROSECUTION BAR INFORMATION from
21 the date of the proceeding until the end of such five (5) day period. Transcripts
22 containing Confidential Information shall have an obvious legend with the
23 appropriate designation on the title page and every subsequent page that the
24 transcript contains Confidential Information. If only portions of a transcript
25 are designated as Confidential Information, then the title page shall be followed
26 by a list of all pages (including line numbers as appropriate) that have been
27 designated as Confidential Information and the level of protection being
asserted by the designating party. The designating party shall inform the court 1 reporter of these requirements.
2 d. for information produced in some form other than documentary
3 and for any other tangible items, designation shall be made by affixing in a
4 prominent place on the exterior of the container or containers in which the
5 information or item is stored the legend “CONFIDENTIAL,” “HIGHLY
6 CONFIDENTIAL – ATTORNEYS’ EYES ONLY,” or “PROSECUTION
7 BAR INFORMATION.” If only a portion or portions of the information or
8 item warrant protection, the producing party, to the extent practicable,
9 shall identify the protected portion(s) and specify the level of protection being
10 asserted.
11 15. A failure to designate qualified information or items, whether by
12 inadvertence or otherwise, does not, standing alone, waive in whole or in part the
13 designating party’s right to secure protection under this Order for such material.
14 Upon subsequent correction of a designation, the receiving party must make
15 reasonable efforts to assure that the material is treated in accordance with any
16 revised designations under the provisions of this Order and promptly collect any
17 copies of the material that have been provided to individuals other than those
18 authorized under Paragraph 6 of this Order. The designating party may also
19 request the individuals to execute the Declaration (Attachment A).
20 16. A party shall not be obligated to challenge the propriety of any
21 Confidential Information designation at the time made, and failure to do so shall not
22 preclude a subsequent challenge. In the event that any party to this Action disagrees
23 at any stage of the proceedings with a confidentiality designation, such party shall
24 provide to the producing party written notice of its disagreement with the
25 designation. The parties shall first try to informally resolve such dispute in good
26 faith. If the dispute cannot be resolved within five (5) business days of the written
27 notice, the party challenging the designation may request appropriate relief from the
Court. The burden of proving that information has been properly designated as 1 Confidential Information is on the party making such designation. Notwithstanding
2 any dispute as to the confidentiality of information, such information shall
3 nevertheless be treated in accordance with the designation that was proposed in
4 accordance with the provisions of this Protective Order unless and until such
5 designation is removed or amended by order of the Court or by written consent of
6 the designating party. Absent a showing of good cause, each side may challenge the
7 confidentiality designations of no more than 20 documents produced by the other
8 side in any week, and no more than 80 documents in any two-month period, except
9 that these limits shall not apply to court filings (without exhibits) or expert reports
10 (without exhibits).
11 PROSECUTION BAR
12 17. For purposes of this paragraph, Prosecution Bar Information is
13 information that is designated as “PROSECUTION BAR INFORMATION” (as set
14 forth in Paragraph 10(c) above) and/or that was designated as “HIGHLY
15 CONFIDENTIAL – ATTORNEYS’ EYES ONLY” before the date of this
16 Protective Order (as set forth in Paragraph 10(d) above), except that
17 PROSECUTION BAR INFORMATION does not include financial information.
18 Absent written consent from the producing party or an order by the Court, every
19 person who receives, or in the case of outside counsel who receives and reviews,
20 PROSECUTION BAR INFORMATION is precluded from performing, or
21 providing (verbally or in tangible form, in whole or in part) such Confidential
22 Information received under this Order to any person involved in performing, the
23 following tasks: drafting, prosecuting, or supervising or providing advice regarding
24 the drafting or prosecution, of any patent applications with the United States Patent
25 and Trademark Office (“USPTO”) or any similar proceedings in any other country,
26 involving any patent application having claims or disclosures directed to
27 transcatheter mitral or tricuspid valve repair devices, and methods and devices for the
delivery thereof. This preclusion is limited to proceedings involving patents and 1 patent applications having an effective filing date before this Action, during this
2 Action, or within two (2) years after the final termination of this Action. For
3 purposes of clarity, (1) “prosecution” does not include reexamination, reissue,
4 interference proceedings, or equivalent proceedings (e.g., post-grant review, inter
5 partes review, oppositions) and any similar proceedings in any other country, except
6 that all persons who receive, or in the case of outside counsel of record who receives
7 and reviews, PROSECUTION BAR INFORMATION are prohibited from
8 performing, or providing (verbally or in tangible form, in whole or in part) such
9 Confidential Information received under this Order to any person involved in
10 performing the following tasks: (1) drafting, or supervising or providing advice
11 regarding drafting, new or amended claims in any such proceedings; (2)
12 “supervising” refers to directing others how to draft, prosecute, or provide advice
13 regarding the drafting or prosecution, of any patents and applications in the scope of
14 the Prosecution Bar; merely having authority to perform the prohibited tasks does
15 not amount to being ‘involved in’ such tasks for purposes of this Prosecution Bar; and
16 (3) “having claims or disclosures directed to transcatheter mitral or tricuspid
17 valve repair devices, and methods and devices for the delivery thereof” refers to
18 claims and/or disclosures that specifically mention in words or substance
19 transcatheter mitral or tricuspid valve repair devices, and methods and devices for the
20 delivery thereof. This Prosecution Bar does not apply to any in-house counsel
21 designated under Paragraph 6 who is only provided access to “CONFIDENTIAL”
22 information of an opposing party, or to information designated by an opposing party
23 as “HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES ONLY” after the date of
24 this Protective Order. This Prosecution Bar shall begin when access to
25 PROSECUTION BAR INFORMATION is first received by the affected individual,
26 or in the case of outside counsel first received and reviewed and shall end two (2)
27 years after final termination of this Action.
INADVERTENT DISCLOSURES 1 18. Inadvertent disclosures by the producing party of Confidential
2 Information, regardless of whether the material was so designated at the time of
3 disclosure, shall not be deemed a waiver in whole or in part of a party’s claim of
4 confidentiality, either as to the specific information disclosed or as to any other
5 information relating to the same or related subject matter, provided that the
6 producing party shall promptly upon discovery of the inadvertent disclosure notify
7 the receiving party in writing that the information is Confidential Information and
8 was inadvertently disclosed. Such notification shall constitute a designation of the
9 information as Confidential Information. Upon such notification, counsel shall
10 reasonably cooperate to restore the confidentiality of the Confidential Information
11 to the extent possible. Upon subsequent correction of a designation, the receiving
12 party must make reasonable efforts to assure that the material is treated in
13 accordance with any revised designations under the provisions of this Order and
14 promptly collect any copies of the material that have been provided to individuals
15 other than those authorized under Paragraph 6 of this Order. The designating party
16 may also request the individuals to execute the Declaration (Attachment A).
17 19. Should any Confidential Information be disclosed, through
18 inadvertence or otherwise, by a receiving party to any person not duly authorized to
19 receive such information under this Protective Order, the receiving party must
20 immediately (a) notify in writing the designating party of the unauthorized
21 disclosures, (b) use its best efforts to retrieve all unauthorized copies of the
22 Confidential Information, (c) inform the person or persons to whom unauthorized
23 disclosures were made of all the terms of this Order, and (d) request such person or
24 persons to execute the Declaration (Attachment A).
25 20. The production of material protected by the attorney-client privilege or
26 the work product doctrine or any other applicable privilege (“Privileged Material”),
27 whether inadvertent or otherwise, is not a waiver of the privilege or protection from
discovery in this Action or in any other federal or state proceeding, provided that 1 the producing party notifies the receiving party in writing promptly upon
2 discovery of such information. Upon such notice by the producing party, the
3 receiving party shall not review the Privileged Material in any respect. Within five
4 (5) business days of receiving such notice, the receiving party shall return such
5 information or documents or confirm in writing that it has taken reasonable steps to
6 permanently delete all electronic copies of such documents from electronic records
7 and to destroy all paper copies. If the receiving party has disclosed the information to
8 others before being notified of the claim of privilege or protection, the receiving party
9 must take reasonable steps to retrieve and return or destroy the disclosed
10 information. No use shall be made of such documents or information during
11 deposition or at trial, nor shall such documents or information be shown to anyone
12 after the request that they be returned. The receiving party may move the court for
13 an order compelling production of such information (based on information
14 independent of the content of the allegedly privileged materials in question), but
15 the motion shall not assert as a ground for production the fact or circumstances of the
16 inadvertent production. The producing party must preserve any Privileged Material
17 until all disputes regarding the discoverability of the document(s) have been
18 resolved. If a claim is disputed, the receiving party shall not use or disclose a
19 document or information for which a claim of privilege or immunity is made pursuant
20 to this paragraph for any purpose until the matter is resolved by agreement of the
21 parties or by a decision of this court.
22 21. If a party becomes aware that it has received documents that are
23 clearly privileged, the party receiving the privileged documents will promptly
24 notify the producing party of receipt of the documents and return or destroy all
25 copies of the privileged documents, if the producing party so requests within five (5)
26 business days after being advised of the inadvertent production. If the producing
27 party does not request return or destruction of the identified privileged documents
within this 10-day time period, the producing party will be deemed to have waived 1 the privilege, but only with respect to the specific documents identified.
2 22. Nothing herein shall prevent the receiving party from challenging the
3 propriety of the attorney-client privilege or work-product immunity or other
4 applicable privilege or immunity designation by submitting a written challenge to the
5 Court. The receiving party may object to the producing party’s designation of
6 disclosed information as Privileged Material by providing written notice of such
7 objection within five (5) business days of its receipt of a written demand for the
8 return of the disclosed Privileged Material. Any such objection shall be resolved by
9 the Court after an in camera review of the disclosed Privileged Material.
10 USE OF CONFIDENTIAL INFORMATION IN COURT FILINGS AND
11 FORMAL PROCEEDINGS
12 23. A Party that seeks to file under seal any Confidential Information
13 must comply with C.D. Cal. Local Civil Rule 79-5. Confidential Information may
14 only be filed under seal pursuant to a court order authorizing the sealing of the
15 specific Confidential Information. If a Party’s request to file Confidential
16 Information under seal is denied by the court, then the receiving party may file the
17 information in the public record unless otherwise instructed by the court. The
18 producing party shall cooperate with the filing party and shall provide timely
19 information requested by the filing party, to facilitate the preparation of the
20 Application to File Under Seal required by C.D. Cal. Local Civil Rule 79-5.
21 24. The protections afforded to Confidential Information at trial will be
22 determined by the Court upon an application by any party.
23 25. In the event that any Confidential Information is otherwise used in any
24 Court proceeding in connection with this Action, the parties shall take all steps
25 reasonably required to protect its confidentiality during such use.
26 26. Any person who is not authorized under this Protective Order to have
27 access to Confidential Information may be excluded while a deponent is being
examined about such Confidential Information. 1 MISCELLANEOUS
2 27. The recipient of any Confidential Information agrees to subject
3 himself/herself to the jurisdiction of this Court for the purpose of any proceedings
4 relating to the performance under, compliance with, or violation of this Protective
5 Order.
6 28. The recipient of any Confidential Information that is provided under this
7 Protective Order shall maintain such information in a secure and safe area and
8 shall exercise the same standard of due and proper care, but no less than a
9 reasonable degree of care, with respect to the storage, custody, use and/or
10 dissemination of such information as is exercised by the recipient with respect to its
11 own proprietary information.
12 29. Other Proceedings. Nothing in this Protective Order limits or precludes
13 another court from finding that information may be relevant and subject to disclosure
14 in another case. Any person or party subject to this Order who becomes subject
15 to a motion to disclose another party's information designated CONFIDENTIAL or
16 HIGHLY CONFIDENTIAL – ATTORNEYS’ EYES ONLY or PROSECUTION
17 BAR INFORMATION pursuant to this Protective Order shall promptly notify that
18 party of the motion so that the party may have an opportunity to appear and be
19 heard on whether that information should be disclosed. Nothing in this Protective
20 Order authorizes a person or party to disobey a lawful order or process from another
21 court.
22 30. The restrictions provided for herein shall not terminate upon the
23 conclusion of this Action but shall continue until further order of this Court,
24 provided that this Protective Order shall not be construed to: (a) prevent any party or
25 its counsel from making use of information that was lawfully in its possession prior
26 to its disclosure by the producing party; (b) apply to information that appears in issued
27 patents or printed publications or otherwise becomes publicly known without fault
of any party; or (c) apply to information that any party or its counsel has, since 1 disclosure by the producing party, lawfully obtained from a third party having the
2 right to disclose such information.
3 31. Nothing in this Protective Order shall preclude any party to this
4 Action or their attorneys from: (a) showing a document designated as Confidential
5 Information to an individual who either prepared or reviewed the document prior to
6 the filing of this Action; or (b) disclosing or using, in any manner or for any purpose,
7 any information or documents from the party's own files which the party itself has
8 designated as Confidential Information. Additionally, Confidential Information
9 may be disclosed to a witness at a deposition or in court proceedings if: (a) the
10 witness is an officer, director, or employee of the party that produced such
11 Confidential Information; or (b) the witness is an expert designated under Paragraph
12 6(a)(2).
13 32. Nothing in this Protective Order shall bar or otherwise restrict any
14 counsel from providing legal advice to his or her client solely with respect to this
15 Action and, in the course thereof, relying upon his or her examination of Confidential
16 Information, provided that, in providing such advice and in otherwise communicating
17 with his or her client, such person shall not make any disclosure of Confidential
18 Information or information derived therefrom to any person not entitled to have
19 access to it.
20 33. Nothing in this Protective Order shall prejudice the right of any party to
21 oppose production of any information for lack of relevance, privilege, or any ground
22 other than confidentiality.
23 34. In the event that a party seeks discovery from a non-party to this
24 Action, the non-party may invoke the terms of this Protective Order by advising all
25 parties to this Action in writing.
26 a. The terms of this Order are applicable to information produced
27 by a non-party in this action and designated as Confidential Information.
Such information produced by non-parties in connection with this litigation is 1 protected by the remedies and relief provided by this Order. Nothing in these
2 provisions should be construed as prohibiting a non-party from seeking
3 additional protections.
4 b. Both parties shall be treated as a receiving party with respect to
5 any information produced by a non-party in this action. To the extent that a
6 party obtains information from a non-party via subpoena or otherwise, the party
7 shall produce the information to the other party within 5 business days,
8 unless the party can demonstrate good reason why it is not possible to do so.
9 c. In the event that a party is required, by a valid discovery
10 request, to produce a non-party’s Confidential Information in its possession
11 (other than information produced in this litigation by a non-party), and the
12 party is subject to an agreement with the non-party not to produce the non-
13 party’s Confidential Information, then the party shall:
14 1. promptly notify in writing the requesting party and the
15 non-party that some or all of the information requested is subject to
16 a confidentiality agreement with a non- party;
17 2. promptly provide the non-party with a copy of the
18 Protective Order in this litigation, the relevant discovery request(s), and
19 a reasonably specific description of the information requested; and
20 3. make the information requested available for inspection by
21 the non-party.
22 d. If the non-party fails to object or seek a protective order from the
23 Court within fourteen (14) days of receiving the notice and accompanying
24 information, the receiving party may produce the non- party's confidential
25 information responsive to the discovery request. If the non-party timely seeks
26 a protective order, the receiving party shall not produce any information in
27 its possession or control that is subject to the confidentiality agreement with
the non-party before a determination by the court. Absent a court order to the 1 contrary, the non-party shall bear the burden and expense of seeking
2 protection in this court of its Confidential Information.
3 35. Within ninety (90) days of the termination of this Action (including any
4 appeals), all Confidential Information, all documents describing or summarizing
5 any Confidential Information, and all copies thereof (including without limitation
6 electronic records of documents or information, document coding databases, and
7 other database information), shall, at the election of the receiving party, be returned
8 to the party that produced the same or destroyed. If a receiving party elects to
9 destroy Confidential Information and all copies and summaries thereof, the party
10 shall certify in writing that destruction has taken place within the ninety (90) day time
11 period. Notwithstanding the foregoing, outside counsel may retain an archival copy
12 of any materials filed with the Court, correspondence, deposition transcripts, and/or
13 attorney work product which contains Confidential Information. Such archival
14 documents shall be retained and treated in accordance with this Protective Order.
15 36. This Protective Order is without prejudice to the right of any party to
16 seek relief from the Court from any of its provisions, or to bring before the Court
17 at any time the question of whether any greater or lesser restrictions should be placed
18 upon the disclosure of Confidential Information.
19 37. By stipulating to the entry of this Protective Order, no party waives
20 any right it otherwise would have to object to disclosing or producing any
21 information or item on any ground not addressed in this Protective Order. Similarly,
22 no party waives any right to object on any ground to the use in evidence of any of the
23 material covered by this Protective Order.
24 38. Confidential Information constituting technical and other product
25 development information regarding non-accused products currently in development,
26 including variants of previously released products, may be redacted from Exchanged
27 Information if it is not responsive to the other party’s discovery requests. Any
challenge to such a redaction must be made in accordance with the procedures in 1 | Paragraph 16 above. 2 39. This Protective Order may be amended as need may arise by written 3 || agreement of the parties, subject to court approval. FOR GOOD CAUSE SHOWN, IT IS SO ORDERED. ba MO frees DATED: September 17, 2019 8 JOHN D. EARLY 9 United States Magistrate Judge 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
1 ATTACHMENT A
2
3 IN THE UNITED STATES DISTRICT COURT
4 FOR THE CENTRAL DISTRICT OF CALIFORNIA EDWARDS LIFESCIENCES ) Case No. 8:19-cv-345 5 CORPORATION, a Delaware ) corporation, and EDWARDS ) DECLARATION REGARDING A 6 LIFESCIENCES LLC, a Delaware ) PROTECTIVE ORDER ON corporation ) 7 ) CONFIDENTIALITY Plaintiffs, ) 8 ) v. ) 9 ) ABBOTT CARDIOVASCULAR ) 10 SYSTEMS, INC., a California ) corporation, ) 11 ) Defendant. ) 12 )
13
14 In consideration of the disclosure to me of certain information which is subject
15 to the Protective Order on Confidentiality of this Court (the "Protective Order"), I
16 declare and state under penalty of perjury as follows:
17 1. I have read the Protective Order and I agree to be bound by its terms
18 and to comply with all of its provisions. I will hold in confidence, will not disclose
19 to anyone other than those persons specifically authorized by the Protective Order,
20 and will not copy or use for purposes other than for this lawsuit, any information
21 designated under the Protective Order, except as expressly permitted in the
22 Protective Order. I agree to take reasonable steps to return or destroy and certify
23 destruction of all materials designated under the Protective Order which come into
24 my possession, and documents or things which I have prepared relating thereto, to
25 counsel for the party for whom I was employed or retained. I will do this
26 immediately upon receiving a request from the counsel for the party for whom I was
27 employed or retained or, in any event, by no later than thirty (30) days after I have 1 for taking measures to ensure that staff members working under my supervision
2 comply with the terms of this Protective Order.
3 2. I understand that if I violate the terms of the Protective Order, I will be
4 in violation of a court order and subject to sanctions or other remedies that may be
5 imposed by the court and potentially liable in a civil action for damages.
6 3. I agree to submit myself to the personal jurisdiction of this Court for the
7 purpose of enforcement of this Protective Order, even if such enforcement
8 proceedings occur after termination of this action.
9
10 Date: _______________ By: _________________________________
11 Name: _______________________________
12 Address: _____________________________
13 _____________________________________
14 _____________________________________
15
16
17
18
19
20
21
22
23
24
25
26
27
Reference
- Status
- Unknown